• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

充血性心力衰竭中增强的乙酰胆碱和P2Y受体刺激的血管内皮依赖性超极化因子介导的血管舒张。

Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure.

作者信息

Malmsjö M, Bergdahl A, Zhao X H, Sun X Y, Hedner T, Edvinsson L, Erlinge D

机构信息

Department of Internal Medicine, Lund University Hospital, Sweden.

出版信息

Cardiovasc Res. 1999 Jul;43(1):200-9. doi: 10.1016/s0008-6363(99)00062-0.

DOI:10.1016/s0008-6363(99)00062-0
PMID:10536705
Abstract

OBJECTIVE

Congestive heart failure (CHF) is accompanied by impaired peripheral blood flow and endothelial dysfunction with decreased release of nitric oxide (NO). Strong evidence supports the existence of another vasodilatory substance, endothelium derived hyperpolarising factor (EDHF), which has not previously been studied in CHF.

METHOD

CHF was induced by left coronary artery ligation resulting in a reproducible myocardial infarction in Sprague Dawley rats. Vasodilatory responses to acetylcholine and extracellular nucleotides (ATP, ADP beta S, ADP and UTP) were examined in cylindrical segments of the mesenteric artery, precontracted with noradrenaline. The combined NO- and EDHF-dilatation (after inhibition of cyclo-oxygenase pathways) was called "total dilatation", as indomethacin had only minor effects in this system. NO-dilatation was studied in segments pretreated with indomethacin and the potassium channel inhibitors charybdotoxin (10(-7.5) M) and apamin (10(-6) M), while EDHF-dilatations were studied in the presence of indomethacin (10(-5) M) and L-NOARG (10(-3.5) M).

RESULTS

EDHF-dilatations in CHF were strongly up-regulated for ACh (36% vs. 73%; sham vs. CHF operated rats), ADP beta S (10% vs. 42%), ADP (0% vs. 21%) and UTP (3% vs. 35%). These dilatations were abolished by a combination of charybdotoxin and apamin, confirming that they were mediated by EDHF. The NO-dilatations on the other hand were down-regulated in CHF as compared to sham operated rats for ACh (93% vs. 76%; sham vs. CHF operated rats), ADP beta S (61% vs. 37%). ADP (60% vs. 30%), ATP (49% vs. 34%) and UTP (65% vs. 47%), while a minor decrease was seen in the total dilatation for ACh (87% vs. 75%; sham vs. CHF operated rats), ADP beta S (47% vs. 42%), ADP (59% vs. 39%), ATP (52% vs. 39%) and UTP (59% vs. 44%).

CONCLUSION

In this model of non-atherosclerotic CHF there was a minor decrease in the total dilatation and a marked down-regulation of the NO-mediated dilatation, while the EDHF-dilatation was up-regulated. Increased EDHF-activity in CHF may represent a compensatory response to decreased NO-activity to preserve endothelial function and tissue perfusion.

摘要

目的

充血性心力衰竭(CHF)伴有外周血流受损和内皮功能障碍,一氧化氮(NO)释放减少。有力证据支持另一种血管舒张物质——内皮衍生超极化因子(EDHF)的存在,此前尚未在CHF中对其进行研究。

方法

通过结扎左冠状动脉诱导CHF,在Sprague Dawley大鼠中导致可重复的心肌梗死。在用去甲肾上腺素预收缩的肠系膜动脉圆柱段中,检测对乙酰胆碱和细胞外核苷酸(ATP、β,γ-亚甲基二磷酸腺苷(ADPβS)、ADP和UTP)的血管舒张反应。在抑制环氧化酶途径后,NO和EDHF联合介导的舒张(“总舒张”),因为吲哚美辛在该系统中作用较小。在用吲哚美辛以及钾通道抑制剂蝎毒素(10^(-7.5)M)和蜂毒明肽(10^(-6)M)预处理的节段中研究NO介导的舒张,而在存在吲哚美辛(10^(-5)M)和L-硝基精氨酸甲酯(L-NOARG,10^(-3.5)M)的情况下研究EDHF介导的舒张。

结果

CHF中对乙酰胆碱(假手术组与CHF手术组大鼠:36%对73%)、ADPβS(10%对42%)、ADP(0%对21%)和UTP(3%对35%)的EDHF介导的舒张显著上调。这些舒张反应被蝎毒素和蜂毒明肽的联合使用所消除,证实它们是由EDHF介导的。另一方面,与假手术组大鼠相比,CHF中对乙酰胆碱(93%对76%)、ADPβS(61%对37%)、ADP(60%对30%)、ATP(49%对34%)和UTP(65%对47%)的NO介导的舒张下调,而对乙酰胆碱(87%对75%)、ADPβS(47%对42%)、ADP(59%对39%)、ATP(52%对39%)和UTP(59%对44%)的总舒张有轻微下降。

结论

在这种非动脉粥样硬化性CHF模型中,总舒张有轻微下降,NO介导的舒张显著下调,而EDHF介导的舒张上调。CHF中EDHF活性增加可能代表对NO活性降低的一种代偿反应,以维持内皮功能和组织灌注。

相似文献

1
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure.充血性心力衰竭中增强的乙酰胆碱和P2Y受体刺激的血管内皮依赖性超极化因子介导的血管舒张。
Cardiovasc Res. 1999 Jul;43(1):200-9. doi: 10.1016/s0008-6363(99)00062-0.
2
P2X receptors counteract the vasodilatory effects of endothelium derived hyperpolarising factor.P2X受体可抵消内皮源性超极化因子的血管舒张作用。
Eur J Pharmacol. 2000 Feb 25;390(1-2):173-80. doi: 10.1016/s0014-2999(00)00010-8.
3
P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation.P2U受体介导内皮依赖性但不依赖一氧化氮的血管舒张。
Br J Pharmacol. 1998 Feb;123(4):719-29. doi: 10.1038/sj.bjp.0701660.
4
Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.大鼠肝动脉中内皮源性舒张因子之间的相互作用:聚焦于内皮依赖性超极化因子的调节
Br J Pharmacol. 1998 Jul;124(5):992-1000. doi: 10.1038/sj.bjp.0701893.
5
Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery.电压依赖性钾通道参与内皮衍生超极化因子介导的大鼠肝动脉舒张
Br J Pharmacol. 1997 May;121(1):141-9. doi: 10.1038/sj.bjp.0701108.
6
Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries.充血性心力衰竭导致阻力动脉中P2X1受体下调。
Cardiovasc Res. 1999 Jul;43(1):219-27. doi: 10.1016/s0008-6363(99)00060-7.
7
Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries.大鼠离体小肠系膜动脉中ATP和UTP从扩张到管腔灌注的扩散
J Physiol. 2007 Jul 1;582(Pt 1):335-47. doi: 10.1113/jphysiol.2007.135202. Epub 2007 May 3.
8
Organ culture: a new model for vascular endothelium dysfunction.器官培养:血管内皮功能障碍的一种新模型。
BMC Cardiovasc Disord. 2002 May 5;2:8. doi: 10.1186/1471-2261-2-8.
9
Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery.钾通道在大鼠肝动脉中对硝基精氨酸耐药的内皮依赖性舒张中的作用
Br J Pharmacol. 1996 Apr;117(7):1600-6. doi: 10.1111/j.1476-5381.1996.tb15327.x.
10
An endothelium-derived factor modulates purinergic neurotransmission to mesenteric arterial smooth muscle of hamster.一种内皮衍生因子调节对仓鼠肠系膜动脉平滑肌的嘌呤能神经传递。
Eur J Pharmacol. 2003 Feb 14;461(2-3):129-37. doi: 10.1016/s0014-2999(03)01291-3.

引用本文的文献

1
THE effect of P2X7 receptor activation on functional responses of human left internal mammary artery.P2X7受体激活对人左乳内动脉功能反应的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):2027-2037. doi: 10.1007/s00210-024-03411-1. Epub 2024 Sep 3.
2
Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias.冠状动脉扩张患者脂肪酸的代谢组学特征
Front Physiol. 2021 Nov 19;12:770223. doi: 10.3389/fphys.2021.770223. eCollection 2021.
3
Impaired UTP-induced relaxation in the carotid arteries of spontaneously hypertensive rats.
自发性高血压大鼠颈动脉中 UTP 诱导松弛受损。
Purinergic Signal. 2020 Sep;16(3):453-461. doi: 10.1007/s11302-020-09721-2. Epub 2020 Aug 29.
4
Apelin inhibits an endothelium-derived hyperpolarizing factor-like pathway in rat cerebral arteries.Apelin 抑制大鼠脑血管内皮衍生的超极化因子样通路。
Peptides. 2020 Oct;132:170350. doi: 10.1016/j.peptides.2020.170350. Epub 2020 Jun 21.
5
Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.慢性心力衰竭的运动训练:改善骨骼肌氧气运输与利用
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1419-39. doi: 10.1152/ajpheart.00469.2015. Epub 2015 Aug 28.
6
Cardiac purinergic signalling in health and disease.健康与疾病中的心脏嘌呤能信号传导
Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20.
7
Maternal nutrient restriction during pregnancy impairs an endothelium-derived hyperpolarizing factor-like pathway in sheep fetal coronary arteries.孕期母体营养限制损害绵羊胎儿冠状动脉内皮衍生超极化因子样通路。
Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H134-42. doi: 10.1152/ajpheart.00595.2013. Epub 2014 May 9.
8
Skeletal muscle microvascular oxygenation dynamics in heart failure: exercise training and nitric oxide-mediated function.心力衰竭时骨骼肌微血管氧合动力学:运动训练和一氧化氮介导的功能。
Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H690-8. doi: 10.1152/ajpheart.00901.2013. Epub 2014 Jan 10.
9
The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure.肿瘤坏死因子-α/鞘氨醇-1-磷酸信号轴驱动心力衰竭中的肌源性反应。
J Vasc Res. 2013;50(3):177-85. doi: 10.1159/000350528. Epub 2013 Apr 16.
10
Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.可诱导的内皮源性超极化因子:15-脂氧合酶-EDHF 通路的作用。
J Cardiovasc Pharmacol. 2013 Mar;61(3):176-87. doi: 10.1097/FJC.0b013e31828165db.